Skip to content
10-K

Annual Report

SPRINGWORKS THERAPEUTICS, INC.

0001773427-25-000010

← back to feed
Filed
Feb 20, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 14, 2025 74.94M sh
Shares Diluted FY 2024 · Dec 31, 2024 74.13M sh
Shares Diluted FY 2024 · Dec 31, 2023 63.12M sh
Shares Diluted FY 2024 · Dec 31, 2022 53.29M sh
Stock Repurchased FY 2024 · Dec 31, 2024 $8.44M
Stock Repurchased FY 2024 · Dec 31, 2023 $2.8M
Stock Repurchased FY 2024 · Dec 31, 2022 $1.34M
Capex FY 2024 · Dec 31, 2024 $4.45M
Capex FY 2024 · Dec 31, 2023 $7.39M
Capex FY 2024 · Dec 31, 2022 $10.2M
Operating Cash Flow FY 2024 · Dec 31, 2024 −$175.6M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$222.8M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$161.56M
Cash And Equivalents FY 2024 · Dec 31, 2024 $69.75M
Cash And Equivalents FY 2024 · Dec 31, 2023 $176.05M
Stockholders Equity FY 2024 · Dec 31, 2024 $481.1M
Stockholders Equity FY 2024 · Dec 31, 2023 $626.22M
Stockholders Equity FY 2024 · Dec 31, 2022 $558.19M
Stockholders Equity FY 2024 · Dec 31, 2021 $422.4M
Current Liabilities FY 2024 · Dec 31, 2024 $99.99M
Current Liabilities FY 2024 · Dec 31, 2023 $78.17M
Total Liabilities FY 2024 · Dec 31, 2024 $106.17M
Total Liabilities FY 2024 · Dec 31, 2023 $99.57M
Current Assets FY 2024 · Dec 31, 2024 $380.47M
Current Assets FY 2024 · Dec 31, 2023 $500.91M
Total Assets FY 2024 · Dec 31, 2024 $587.28M
Total Assets FY 2024 · Dec 31, 2023 $725.79M
Eps Diluted FY 2024 · Dec 31, 2024 −$3.48
Eps Diluted FY 2024 · Dec 31, 2023 −$5.15
Eps Diluted FY 2024 · Dec 31, 2022 −$5.21
Eps Basic FY 2024 · Dec 31, 2024 −$3.48
Eps Basic FY 2024 · Dec 31, 2023 −$5.15
Eps Basic FY 2024 · Dec 31, 2022 −$5.21
Sga Expense FY 2024 · Dec 31, 2024 $256.65M
Sga Expense FY 2024 · Dec 31, 2023 $197.55M
Sga Expense FY 2024 · Dec 31, 2022 $134.55M
Rd Expense FY 2024 · Dec 31, 2024 $200.52M
Rd Expense FY 2024 · Dec 31, 2023 $150.49M
Rd Expense FY 2024 · Dec 31, 2022 $146.12M
Net Income FY 2024 · Dec 31, 2024 −$258.13M
Net Income FY 2024 · Dec 31, 2023 −$325.1M
Net Income FY 2024 · Dec 31, 2022 −$277.42M
Operating Income FY 2024 · Dec 31, 2024 −$278.13M
Operating Income FY 2024 · Dec 31, 2023 −$343.01M
Operating Income FY 2024 · Dec 31, 2022 −$280.67M
Cost Of Revenue FY 2024 · Dec 31, 2024 $12.55M
Cost Of Revenue FY 2024 · Dec 31, 2023 $422K
Cost Of Revenue FY 2024 · Dec 31, 2022 $0
Revenue FY 2024 · Dec 31, 2024 $191.59M
Revenue FY 2024 · Dec 31, 2023 $5.45M
Revenue FY 2024 · Dec 31, 2022 $0